Ms. Jean Hoffman

• 
  www.masshightech.com/stories/2009/07/13/weekly13-Drug-c - [Cached Version]
  Published on: 7/17/2009    Last Visited: 7/22/2009  

  Jean Hoffman, CEO of Putney Inc.
  ...
  CEO Jean Hoffman said the eureka moment came after she adopted a black cat named Dude, who needed to take an expensive human thyroid medicine. "I thought, I can make this cheaper and easier to administer by making a pet version," she said.

• 
  www.masshightech.com/stories/2008/10/13/weekly13-Maine- - [Cached Version]
  Published on: 10/17/2008    Last Visited: 10/21/2008  

  Jean Hoffman is the founder and CEO the 2-year-old company and, of course, a major pet lover. But she doesn't just bring a love for animals to the job — Hoffman spent her entire career in bulk-pharmaceutical manufacturing and generic drug-focused companies.
  
  In 1990 Hoffman founded Newport Strategies LLC, a consulting firm to the generics industry, which was later bought by Thomson-Reuters Corp. in 2004. Soon after, she started another generics consulting firm called Q Street Advisors.
  
  The idea of starting a generics development company for pets originally came to Hoffman when Dude, her adopted cat, developed hyperthyroidism, a common condition in older cats. The medication that Dude needed was not available in generic form and cost $30 a month. Later, the dosage doubled, as did the cost.
  
  "The concept of needing generic products for pets just stuck in my mind. Not everyone can afford spending $60 a month for their pets," Hoffman said.
  
  To maximize the company's development efforts, Hoffman used the analytical research tools and algorithms developed at Newport Strategies to identify drugs with the highest potential for profitability.

• 
  www.biospace.com/news_story.aspx?NewsEntityId=112421&So - [Cached Version]
  Published on: 10/8/2008    Last Visited: 10/9/2008  

  Increased availability of generic veterinary medications will enhance the ability of pet owners, who pay out of pocket, to provide their pets with the health care they need," says Jean Hoffman, founder and CEO of Putney, Inc.
  
  Hoffman's comment refers to two studies.Business Week recently reported that purchasing related to domestic companion animals, currently at $41B annually, is the second largest growing category of consumer spending.In a survey by Fleischman Hillard International Communications, fifty per cent of respondents say that a recession would not affect their pet spending.Putney's own focus groups have revealed that veterinarians are open to new generics; especially alternatives to pricey, chronic treatments.
  
  Hoffman, an entrepreneur whose last enterprise, Newport Strategies, sold to Thomson Corporation in 2004, founded Putney to make pet healthcare more affordable and accessible -- a need she recognized when caring for her own aging cats."Pets are cherished family members, yet many, including older pets that need medicines for chronic conditions, are not receiving the full dosage of their veterinarian prescribed medicines due to the high costs of pet pharmaceuticals," she says.Most human pharma products have a generic equivalent available when the patent expires, while 86% of companion animal drugs still have no generic equivalent available years beyond patent expiration.
  
  Hoffman also cites the recently passed Animal Generic Drug User Fee Act as more cause for celebration.

• 
  www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/w - [Cached Version]
  Published on: 10/8/2008    Last Visited: 10/8/2008  

  Increased availability of generic veterinary medications will enhance the ability of pet owners, who pay out of pocket, to provide their pets with the health care they need," says Jean Hoffman, founder and CEO of Putney, Inc.Hoffman's comment refers to two studies.Business Week recently reported that purchasing related to domestic companion animals, currently at $41B annually, is the second largest growing category of consumer spending.In a survey by Fleischman Hillard International Communications, fifty per cent of respondents say that a recession would not affect their pet spending.Putney's own focus groups have revealed that veterinarians are open to new generics; especially alternatives to pricey, chronic treatments.Hoffman, an entrepreneur whose last enterprise, Newport Strategies, sold to Thomson Corporation in 2004, founded Putney to make pet healthcare more affordable and accessible -- a need she recognized when caring for her own aging cats."Pets are cherished family members, yet many, including older pets that need medicines for chronic conditions, are not receiving the full dosage of their veterinarian prescribed medicines due to the high costs of pet pharmaceuticals," she says.Most human pharma products have a generic equivalent available when the patent expires, while 86% of companion animal drugs still have no generic equivalent available years beyond patent expiration.Hoffman also cites the recently passed Animal Generic Drug User Fee Act as more cause for celebration.

• 
  www.prnewswire.com/cgi-bin/stories.pl?ACCT=109&STORY=/w - [Cached Version]
  Published on: 8/14/2008    Last Visited: 8/19/2008  

  Jean Hoffman, CEO of Putney, a GADA member company, commented "The AGDUFA legislation marks the beginning of a new era for animal health.

• 
  www.thedailycat.com/Health/cat_medicine/index.html - [Cached Version]
  Last Visited: 10/4/2009  

  These medications usually still derive from branded human drugs, according to Jean Hoffman, founder and CEO of Putney Inc., a Portland, Maine-based company that aims to develop generic versions of commonly used drugs. "There is a tremendous need to bring to market dosing and flavors that are right for cats, and we've focused on doing that," she says.

• 
  tcprod.thomson.com/common/view_news_release.jsp?body_in - [Cached Version]
  Published on: 9/27/2003    Last Visited: 5/3/2004  

  Current Newport CEO and Founder, Jean Hoffman, expressed similar enthusiasm saying, "We have great confidence that Newport's capabilities and intelligence combined with the Thomson global reach and leadership in the pharmaceutical industry will bring great benefit to our customers."

• 
  www.vantulleken.com/newsitem30.aspx - [Cached Version]
  Published on: 4/1/2004    Last Visited: 11/12/2007  

  Current Newport CEO and Founder, Jean Hoffman, expressed similar enthusiasm saying, "we have great confidence that Newport's capabilities and intelligence combined with the Thomson global reach and leadership in the pharmaceutical industry will bring great benefit to our customers."

• 
  www.mpbn.net/News/MaineNews/tabid/181/ctl/ViewItem/mid/ - [Cached Version]
  Published on: 8/24/2009    Last Visited: 9/4/2009  

  CEO Jean Hoffman spoke with Josie Huang about why Putney has branched out.
  ...
  Jean Hoffman: "The 'eureka moment' of developing the idea to do generic drugs for pets was when I had an old cat and my cat developed hyperthyroidism which is common in older kitties and I had to give him a pill once a day.
  ...
  Hoffman: "Good question.
  ...
  Hoffman: "The pet pharmacuetical indsutry has been dominated by what we call 'big Pharma' animal health.
  ...
  Hoffman: "We are continuing to offer for sale selected human products that vets wants to use for pets that offer an option where there isn't a vet-approved drug or where the vets feel there is an opportunity to save money.
  ...
  Hoffman: "The savings should be pretty significant, in the range of 25-30 percent.
  ...
  Hoffman: "The human generics industry is very, very competitive. It's very, very efficient.
  ...
  Hoffman: "Veterinarians tell us if they could get more affordable generics for some of the particularly expensive medicines, it would change the way they practice medicine because they could afford to use the standard of care drug as first-line therapy instead of so often substituting a human drug that is less efficacious in order to help the pet owners save money.

• 
  7th Annual Generic Drugs Summit - Agenda - Day One - [Cached Version]
  Published on: 8/11/2004    Last Visited: 6/15/2006  

  Jean Hoffman, President, Q STREET ADVISORS, INC.& PUTNEY, INC.

Page:  1 2 3